VHCP Management II’s Ocera Therapeutics, Inc. OCRX Stock Holding History

VHCP Management II’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-477,269	Closed	-$544K	–	24
2017 Q3	$544K	Sell	477,269 -740,603	-61%	-$794K	0.15%	20
2017 Q2	$1.41M	Hold	1,217,872	–	–	0.56%	16
2017 Q1	$1.59M	Hold	1,217,872	–	–	0.65%	17
2016 Q4	$2.56M	Buy	1,217,872 +129,500	+12%	+$302K	1.23%	17
2016 Q3	$2.87M	Buy	1,088,372 +140,000	+15%	+$350K	1.47%	19
2016 Q2	$1.8M	Hold	948,372	–	–	1.09%	18
2016 Q1	$2.79M	Buy	+948,372	New	+$2.71M	1.83%	17

VHCP Management II's OCRX Position: Q4 2017 in Review

VHCP Management II sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 477,269 shares — an estimated $544K sold.

VHCP Management II first reported a position in OCRX in Q1 2016 and held it in 7 quarters. The position peaked at $2.87M in Q3 2016. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

VHCP Management II reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
VHCP Management II sold 477,269 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $544K.
VHCP Management II first reported a position in Ocera Therapeutics, Inc. in Q1 2016 and held it in 7 quarters.
VHCP Management II's Ocera Therapeutics, Inc. position peaked at $2.87M in Q3 2016.
0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on VHCP Management II's 13F filing for Q4 2017, filed 13 Feb 2018.